Keyphrases
Activity Level
13%
Acute Myeloid Leukemia
13%
ALDH Activity
13%
Allograft
13%
Atypical Teratoid Rhabdoid Tumor (AT/RT)
14%
Autopsy
26%
BMI1
13%
Bone Marrow
13%
Clinical Model
13%
Convection-enhanced Delivery
13%
Culture Method
15%
Diffuse Intrinsic Pontine Glioma
100%
Diffuse Midline Glioma
13%
Drug Uptake
13%
Gemcitabine
13%
Gene Expression Profile
15%
Glioma Cells
25%
H3K27M
15%
Heterogeneous Susceptibility
13%
High-grade Glioma
20%
In Vitro Culture
13%
International Experience
26%
Leukemic Stem Cells
13%
Mesenchymal Transition
13%
Microglia
13%
Microvascular Pattern
13%
Model-driven Development
13%
Mouse Model
13%
Multi-regional
13%
Neuro-oncology
13%
Neurospheres
23%
Normal Hematopoietic Stem Cells
13%
Oncolytic Virus
13%
Patient-derived
18%
Patient-derived Xenograft
27%
Pediatric
26%
Pediatric Brain Tumor
33%
Pediatric Glioma
31%
Pegylated Liposomal Doxorubicin
13%
Preclinical Evaluation
13%
Senescence
13%
Signaling Pathway
13%
Sirtuin 1 (SIRT1)
13%
Syngeneic
13%
Targeted Therapy
13%
Thalamic
13%
Therapeutic Vulnerabilities
13%
Tumor
28%
Tumor Drugs
13%
Unique Genes
13%
Medicine and Dentistry
Allograft
13%
Anthracycline
5%
Atypical Teratoid Rhabdoid Tumor
14%
Biopsy Technique
13%
Ganglioglioma
29%
Gemcitabine
13%
Gene Expression
14%
Glioma Cell
6%
Immunotherapy
14%
In Vitro
17%
Intracranial Tumor
10%
Laminin
5%
Microglia
13%
Neoplasm
21%
Oncolytic Virus
13%
Pediatric Brain Tumor
29%
Pediatrics
29%
Polyethylene Terephthalate
13%
Pontine Glioma
39%
Protein P53
13%
Sirtuin 1
13%
Thalamus
7%
Tumor Progression
8%
Xenograft
14%